Caption Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-50,000
Closed -$4.8M 1865
2025
Q4
$4.8M Hold
50,000
0.03% 534
2025
Q3
$4.76M Sell
50,000
-100,000
-67% -$9.19M 0.04% 509
2025
Q2
$13.1M Sell
150,000
-80,000
-35% -$6.78M 0.14% 154
2025
Q1
$20.7M Buy
+230,000
New +$20.6M 0.2% 91
2024
Q1
Sell
-171,000
Closed -$14.1M 1491
2023
Q4
$14.1M Buy
+171,000
New +$13M 0.19% 133
2022
Q3
Sell
-27,400
Closed -$2.46M 1713
2022
Q2
$2.46M Buy
+27,400
New +$2.78M 0.03% 603
2022
Q1
Sell
-147,000
Closed -$15.2M 1748
2021
Q4
$15.2M Sell
147,000
-3,000
-2% -$347K 0.17% 148
2021
Q3
$18.8M Buy
+150,000
New +$19.4M 0.22% 103

Other funds holding MDT

Caption Management's MDT Position: Q4 2025 in Review

Caption Management sold out of Medtronic (MDT) in Q4 2025, closing a stake of 11,700 shares — an estimated $1.14M sold.

Caption Management first reported a position in MDT in Q3 2019 and held it in 9 quarters. The position peaked at $17.5M in Q4 2021. 2,303 funds tracked by Wall St. Rank hold MDT as of Q4 2025.

  • Caption Management reported no remaining Medtronic position as of Q4 2025 after selling out during the quarter.
  • Caption Management sold 11,700 Medtronic shares in Q4 2025, an estimated $1.14M.
  • Caption Management first reported a position in Medtronic in Q3 2019 and held it in 9 quarters.
  • Caption Management's Medtronic position peaked at $17.5M in Q4 2021.
  • 2,303 funds tracked by Wall St. Rank held Medtronic as of Q4 2025.

Based on Caption Management's 13F filing for Q4 2025, filed 17 Feb 2026.